Two drug pages, no figures
Semaglutide and tirzepatide each get a dedicated page. Neither carries a price token. Its homepage renders under two and a half thousand characters, so there is very little to read before the intake.
This is a census, not an impression: we fetched the homepage, both drug pages, the about page, the privacy policy and the terms of service, and searched the extracted text of each.
A banner where a list should be
The site says its providers care for patients across all fifty states. That is a claim in prose, not a list, and no list appears. We have recorded the claim as the seller makes it and marked in the review that it is a banner.
One instrument note worth carrying: a path that does not exist on this host returns a not-found with a body larger than most real pages in this batch. A sweep judging pages by size would call that one live.
No compounding pharmacy is named, no prescribing clinician is named, and nothing is said in either direction about a membership fee.
SamaritanMD's published pricing
| Medication | Price | Verified |
|---|
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 240 providers reviewed here are paid partners today; the other 236 are not. See how this works.
See SamaritanMD's current price →Good fit if
- Readers who want each molecule on its own page.
- Buyers who want the class of compounding facility stated.
- People comparing sellers that publish nothing before an intake.
Look elsewhere if
- Anyone who needs a price.
- Readers who want a real service-area list.
- Buyers who want a named pharmacy or clinician.
- People who need the membership question answered.
How this review was verified
- Re-read the homepage, both drug pages, the about page, the privacy policy and the terms on 7 September 2026, comparing requested to effective URLs with a nonsense path against the host in the same run.
- Searched the extracted text of all six pages for a price token and found none, and recorded that census rather than an impression.
- Recorded that the nonsense path returned a not-found with a very large body, so no judgement here rests on a byte count.
- Read the operating company in its privacy policy and read the three tracker disclosures in context, rejecting each as an entity.
- Screened the brand against FDA’s live warning-letter datatable with both controls green: no letter found.